✦ LIBER ✦

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: Results of a North Central Cancer Treatment Group randomized clinical trial

Book ID: 123153771
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 149 KB
Volume: 11
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)90621-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized double-blind placebo-controll

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Bolus versus infusion regimens of etopos

Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: A study of the North Central Cancer Treatment Group

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Cost-effectiveness analysis of cisplatin

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer

✍ Sumitra THONGPRASERT; Unchalee PERMSUWAN; Chidchanok RUENGORN; Chaiyut CHAROENTU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor